Altered expression of miR-146a in myasthenia gravis

[1]  Huan Yang,et al.  Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis , 2012, Inflammation.

[2]  U. Testa,et al.  The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer , 2012, Journal of Hematology & Oncology.

[3]  S. Booth,et al.  MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State , 2012, PloS one.

[4]  W. Lukiw,et al.  Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain , 2012, Molecular Neurobiology.

[5]  G. Papp,et al.  Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. , 2012, Immunology letters.

[6]  N. Bresolin,et al.  Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis , 2011, Neuroscience Letters.

[7]  Kaleb M. Pauley,et al.  Altered miR‐146a expression in Sjögren's syndrome and its functional role in innate immunity , 2011, European journal of immunology.

[8]  S. Monticelli,et al.  MiR-146a in Immunity and Disease , 2011, Molecular biology international.

[9]  Yuhai Zhao,et al.  Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[10]  N. Adachi,et al.  MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients , 2010, BMC musculoskeletal disorders.

[11]  K. Herkner,et al.  MicroRNA-146: Tiny Player in Neonatal Innate Immunity? , 2010, Neonatology.

[12]  S. Hammond,et al.  Emerging paradigms of regulated microRNA processing. , 2010, Genes & development.

[13]  M. Bellio,et al.  TLR4 Promotes B Cell Maturation: Independence and Cooperation with B Lymphocyte-Activating Factor , 2010, The Journal of Immunology.

[14]  J. C. Baayen,et al.  Expression pattern of miR‐146a, an inflammation‐associated microRNA, in experimental and human temporal lobe epilepsy , 2010, The European journal of neuroscience.

[15]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[16]  Francesca Meloni,et al.  An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. , 2010, Blood.

[17]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[18]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[19]  Kaleb M. Pauley,et al.  Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2008, Arthritis research & therapy.

[20]  S. Le,et al.  Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth , 2008, PloS one.

[21]  Xiao-hong Ma,et al.  [Expression of Toll-like receptors in thymus of myasthenia gravis patients]. , 2008, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[22]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[23]  D. Gray,et al.  TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells , 2007, European journal of immunology.

[24]  S. Gerondakis,et al.  Regulating B‐cell activation and survival in response to TLR signals , 2007, Immunology and cell biology.

[25]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[26]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Chris Sander,et al.  MicroRNA profiling of the murine hematopoietic system , 2005, Genome Biology.

[28]  E. Arnoldi,et al.  Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution. , 2005, The American journal of pathology.

[29]  B. Machiels,et al.  Immunoregulation in Experimental Autoimmune Myasthenia Gravis—about T Cells, Antibodies, and Endplates , 2003, Annals of the New York Academy of Sciences.

[30]  H. Link,et al.  Rat models as tool to develop new immunotherapies , 2001, Immunological reviews.

[31]  J. Palace,et al.  Myasthenia gravis , 2001, The Lancet.

[32]  S. Fuchs,et al.  Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. , 1999, The Journal of clinical investigation.

[33]  T. Okarma,et al.  Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. , 1991, Journal of immunology.

[34]  A. Levinson,et al.  Thymic B‐cell activation in myasthenia gravis , 1984, Neurology.

[35]  Kaleb M. Pauley,et al.  Upregulated miR-146 a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2015 .

[36]  N. Adachi,et al.  MicroRNA-146 a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients , 2010 .

[37]  C. Turner.  A review of myasthenia gravis: Pathogenesis, clinical features and treatment , 2007 .

[38]  R. Lisak,et al.  Cell-surface expression of lymphocyte activation markers in myasthenia gravis. , 1999, Autoimmunity.